Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
PACB holding history
Pacific Biosciences of California, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PACB overviewAll 13F holders of PACBFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −2,442,956−100.0% | Sold out | Holders |
| Q4 2023 | 2,442,956 | $24.0M | 0.1% | −1,222,921−33.4% | Reduced | Holders |
| Q3 2023 | 3,665,877 | $30.6M | 0.1% | −17,989−0.5% | Reduced | Holders |
| Q2 2023 | 3,683,866 | $49.0M | 0.2% | +251,862+7.3% | Added | Holders |
| Q1 2023 | 3,432,004 | $39.7M | 0.1% | −780,131−18.5% | Reduced | Holders |
| Q4 2022 | 4,212,135 | $34.5M | 0.1% | +4,212,135 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −1,019,453−100.0% | Sold out | Holders |
| Q1 2021 | 1,019,453 | $34.0M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.